Dennis J. Slamon

University of California, Los Angeles ORCID: 0000-0002-6330-498X

1

h-index

1

Publications

11,312

Citations

Publications

1 shown

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon , Brian Leyland‐Jones , Steven Shak +9 more

Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2.

2001 New England Journal of Medicine 11312 citations

Frequent Co-Authors

Brian Leyland‐Jones

McGill University

Steven Shak

H. Fuchs

Virginia Paton

Alex Bajamonde

Thomas Fleming

University of Washington

Researcher Info

h-index: 1
Publications: 1
Citations: 11,312
Institution: University of California, Los Angeles

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6330-498X

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.